# Jean Frédéric Blanc

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jean-frederic-blanc-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,212 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 19 |
| i10-index | 22 |
| Last Known Institution | Sciences Po Bordeaux |
| OpenAlex ID | https://openalex.org/A5111712866 |
| Works | 44 |

## Researcher papers

- [Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/atezolizumab-plus-bevacizumab-versus-active-surveillance-in-patients-with/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Liver physiology and pathology](https://scholariq.org/topics/liver-physiology-and-pathology/)

## Researcher university

- [Sciences Po Bordeaux](https://scholariq.org/institutions/sciences-po-bordeaux/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.